BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 20206554)

  • 1. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages.
    Ghisletti S; Barozzi I; Mietton F; Polletti S; De Santa F; Venturini E; Gregory L; Lonie L; Chew A; Wei CL; Ragoussis J; Natoli G
    Immunity; 2010 Mar; 32(3):317-28. PubMed ID: 20206554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seq-ing LPS-induced enhancers.
    Smale ST
    Immunity; 2010 Mar; 32(3):296-8. PubMed ID: 20346768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of the cyclooxygenase-2 gene in macrophages by PU.1.
    Joo M; Park GY; Wright JG; Blackwell TS; Atchison ML; Christman JW
    J Biol Chem; 2004 Feb; 279(8):6658-65. PubMed ID: 14966110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The co-activator p300 associates physically with and can mediate the action of the distal enhancer of the FGF-4 gene.
    Nowling T; Bernadt C; Johnson L; Desler M; Rizzino A
    J Biol Chem; 2003 Apr; 278(16):13696-705. PubMed ID: 12488456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin proteomics reveals novel combinatorial histone modification signatures that mark distinct subpopulations of macrophage enhancers.
    Soldi M; Mari T; Nicosia L; Musiani D; Sigismondo G; Cuomo A; Pavesi G; Bonaldi T
    Nucleic Acids Res; 2017 Dec; 45(21):12195-12213. PubMed ID: 28981749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
    Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
    J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Analysis of the Chromatin Landscape Identifies a Repertoire of Murine Eosinophil-Specific PU.1-Bound Enhancers.
    Felton JM; Vallabh S; Parameswaran S; Edsall LE; Ernst K; Wronowski B; Malik A; Kotliar M; Weirauch MT; Barski A; Fulkerson PC; Rothenberg ME
    J Immunol; 2021 Aug; 207(4):1044-1054. PubMed ID: 34330753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1.
    Brass AL; Kehrli E; Eisenbeis CF; Storb U; Singh H
    Genes Dev; 1996 Sep; 10(18):2335-47. PubMed ID: 8824592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatin Remodeler Recruitment during Macrophage Differentiation Facilitates Transcription Factor Binding to Enhancers in Mature Cells.
    McAndrew MJ; Gjidoda A; Tagore M; Miksanek T; Floer M
    J Biol Chem; 2016 Aug; 291(35):18058-18071. PubMed ID: 27382057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between PU.1 and another Ets family transcription factor promotes macrophage-specific Basal transcription initiation.
    Ross IL; Yue X; Ostrowski MC; Hume DA
    J Biol Chem; 1998 Mar; 273(12):6662-9. PubMed ID: 9506963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
    Marecki S; Atchison ML; Fenton MJ
    J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription.
    Wang SP; Tang Z; Chen CW; Shimada M; Koche RP; Wang LH; Nakadai T; Chramiec A; Krivtsov AV; Armstrong SA; Roeder RG
    Mol Cell; 2017 Jul; 67(2):308-321.e6. PubMed ID: 28732206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Ets factors and interferon regulatory factor-4 modulate CD68 expression in a cell type-specific manner.
    O'Reilly D; Quinn CM; El-Shanawany T; Gordon S; Greaves DR
    J Biol Chem; 2003 Jun; 278(24):21909-19. PubMed ID: 12676954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PU.1 and IRF8 Modulate Activation of NLRP3 Inflammasome
    Yashiro T; Yamamoto M; Araumi S; Hara M; Yogo K; Uchida K; Kasakura K; Nishiyama C
    Front Immunol; 2021; 12():649572. PubMed ID: 33897697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Context-dependent Pax-5 repression of a PU.1/NF-kappaB regulated reporter gene in B lineage cells.
    Linderson Y; French NS; Neurath MF; Pettersson S
    Gene; 2001 Jan; 262(1-2):107-14. PubMed ID: 11179673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum response factor utilizes distinct promoter- and enhancer-based mechanisms to regulate cytoskeletal gene expression in macrophages.
    Sullivan AL; Benner C; Heinz S; Huang W; Xie L; Miano JM; Glass CK
    Mol Cell Biol; 2011 Feb; 31(4):861-75. PubMed ID: 21135125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARG binding landscapes in macrophages suggest a genome-wide contribution of PU.1 to divergent PPARG binding in human and mouse.
    Pott S; Kamrani NK; Bourque G; Pettersson S; Liu ET
    PLoS One; 2012; 7(10):e48102. PubMed ID: 23118933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
    Cooper S; Guo H; Friedman AD
    PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperation of PU.1 With IRF8 and NFATc1 Defines Chromatin Landscapes During RANKL-Induced Osteoclastogenesis.
    Izawa N; Kurotaki D; Nomura S; Fujita T; Omata Y; Yasui T; Hirose J; Matsumoto T; Saito T; Kadono Y; Okada H; Miyamoto T; Tamura T; Aburatani H; Tanaka S
    J Bone Miner Res; 2019 Jun; 34(6):1143-1154. PubMed ID: 30721543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.
    Kaikkonen MU; Spann NJ; Heinz S; Romanoski CE; Allison KA; Stender JD; Chun HB; Tough DF; Prinjha RK; Benner C; Glass CK
    Mol Cell; 2013 Aug; 51(3):310-25. PubMed ID: 23932714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.